Annexin Pharmaceuticals AB: First patient treated in the second dose group in Annexin s RVO study finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
STOCKHOLM, Oct. 25, 2023 /PRNewswire/ Annexin Pharmaceuticals announces that all patients in the first dose group with the lowest dose have now completed treatment in the company s clinical phase.